Novel Compounds as Diacylglycerol Acyltransferase Inhibitors
    27.
    发明申请
    Novel Compounds as Diacylglycerol Acyltransferase Inhibitors 有权
    新型化合物作为二酰基甘油酰基转移酶抑制剂

    公开(公告)号:US20140080809A1

    公开(公告)日:2014-03-20

    申请号:US14118976

    申请日:2012-05-18

    IPC分类号: C07D498/04

    CPC分类号: C07D519/00 C07D498/04

    摘要: This invention relates to novel compounds which are inhibitors of acyl coenzymeA: diacylglycerol acyltransferase 1 (DGAT-1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the prevention or treatment of diseases related to DGAT-1 dysfunction or where modulation of DGAT-1 activity may have therapeutic benefit including but not limited to obesity, obesity related disorders, hypertriglyceridemia, hyperlipoproteinemia, chylomicronemia, dyslipidemia, non-alcoholic steatohepatitis, diabetes, insulin resistance, metabolic syndrome, hepatitis C virus infection and acne or other skin disorders.

    摘要翻译: 本发明涉及作为酰基辅酶A:二酰基甘油酰基转移酶1(DGAT-1)的抑制剂的新化合物,含有它们的药物组合物,其制备方法及其在治疗中用于预防或治疗与DGAT有关的疾病 -1功能障碍或DGAT-1活性的调节可能具有治疗益处,包括但不限于肥胖症,肥胖症相关疾病,高甘油三酯血症,高脂蛋白血症,乳糜微粒血症,血脂异常,非酒精性脂肪性肝炎,糖尿病,胰岛素抵抗,代谢综合征,丙型肝炎病毒 感染和痤疮或其他皮肤疾病。